That was fast: After Mother Jones broke the news Monday that the European distributer of the morning after pill would be cautioning women over 165 pounds about the drug's potential ineffectiveness, the FDA says they're looking into those claims to see if packaging for Teva's Plan B and other generic versions of that drug should be altered in the United States.